论文部分内容阅读
目的:探究奥曲肽治疗重症急性胰腺炎的临床效果。方法:选取我院2014年5月-2015年6月收治的100例重症急性胰腺炎患者,按照随机平行的方式分成观察组和对照组,各50例。观察组通过奥曲肽治疗,对照组采取氟尿嘧啶治疗,对比两组临床疗效。结果:观察组的治疗总有效率94%,对照组的治疗总有效率76%,差异具有统计学意义,P<0.05。两组临床各项指标:腹痛缓解和血淀粉酶恢复正常、尿淀粉酶恢复正常和住院的时间进行比较,差异显著,P<0.05。结论:奥曲肽对重症急性胰腺炎治疗,临床疗效较佳,值得临床深入推广。
Objective: To explore the clinical effect of octreotide in the treatment of severe acute pancreatitis. Methods: One hundred patients with severe acute pancreatitis who were admitted to our hospital from May 2014 to June 2015 were randomly divided into observation group and control group, with 50 cases in each group. The observation group was treated with octreotide, the control group was treated with fluorouracil, and the clinical efficacy was compared between the two groups. Results: The total effective rate was 94% in the observation group and 76% in the control group, the difference was statistically significant (P <0.05). The two groups of clinical indicators: the ease of abdominal pain and blood amylase returned to normal, urinary amylase returned to normal and hospitalized for comparison, the difference was significant (P <0.05). Conclusion: Therapeutic effect of octreotide on severe acute pancreatitis is clinically effective and worthy of clinical in-depth promotion.